Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab.
Ari M
AM
Goldminz
Nina C
NC
Botto
Alice B
AB
Gottlieb
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003622:Dapsone / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D000069549:Ustekinumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D003622:Dapsone; D000069549:Ustekinumab; D011241:Prednisone